Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
vanessa.raymont@psych.ox.ac.uk

Telephone
+44 (0)1865 613147

Vanessa Raymont

MBChB MSc FRCPsych

Associate Professor, R&D Director Oxford Health NHS Foundation Trust

Honorary Senior Clinical Research Fellow, University of Edinburgh
Honorary Consultant Psychiatrist

My clinical and research interests are in traumatic brain injury, and memory disorders and dementia, as well as clinical trials in cognitive impairment, having worked for over 25 years in clinical trials in the UK and US.

I am currently the Principal Investigator for the Synaptic Health in Neurodegeneration (SHINE) and Brains for Dementia Research (BDR) studies and multiple commercial early and late phase dementia clinical trials. I am Chief Investigator on the Deep and Frequent Phenotyping (DFP) study, a NHIR-funded study assessing the use of sertraline to prevent post-head injury depression (STOP-D) and am co-lead for the REAl world Dementia OUTcomes (READ-OUT) blood biomarker study that is part of the Alzheimer's Research UK Blood Biomarker Challenge. I am an associate director of Dementia Platforms UK, and workstream lead for the Trials Delivery Framework. I serve as a Commissioner for the Commission on Human Medicines and am co-Deputy Chair of the NIHR Dementia Translational Research Collaboration.

Recent publications

Patient and public involvement and engagement in clinical trials at scale: Analysis of the first 3250 responses on the POrtal for Patient and Public Engagement in Dementia (POPPED).

Qin H. et al, (2026), Alzheimers Dement, 22

Divergence of cortical neurophysiology across different neurodegenerative disorders compared to healthy ageing.

Trubshaw M. et al, (2026), Prog Neurobiol, 257

The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process.

Demnitz-King H. et al, (2026), Nat Rev Neurol, 22, 123 - 135

Digital cognition plus plasma p-Tau217 and Aβ42/40 powerfully predict Alzheimer's progression.

Begde A. et al, (2026), Alzheimers Dement (Amst), 18

Blood biomarkers for diagnosis and differential diagnosis of Alzheimer's disease in real-world clinical populations: A systematic review.

Suresh S. et al, (2025), J Alzheimers Dis, 109

Lecanemab appropriate use recommendations for clinical practice in the UK.

Mummery CJ. et al, (2025), J Neurol Neurosurg Psychiatry

Public Health.

Gillis G. et al, (2025), Alzheimers Dement, 21 Suppl 6

Alzheimer's Imaging Consortium.

Gillis G. et al, (2025), Alzheimers Dement, 21 Suppl 8

Dementia Care Research and Psychosocial Factors.

DU J. et al, (2025), Alzheimers Dement, 21 Suppl 4

Drug Development

Iqbal S. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Biomarkers

Mitchell J. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Biomarkers

Krugliak A. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Characterisation of long‐term conditions in a memory clinic population: A UK Biobank comparison study

Gillis G. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

Retinal biomarkers for Alzheimer's disease in the prodromal and preclinical population ‐ The Deep and Frequent Phenotyping study

Mitchell J. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

Repurposed Drug Prioritisation Pipeline for an Alzheimer’s Disease Multi‐arm Platform Trial

Iqbal S. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

Multimodal MRI reveals distinct patterns of vascular and microstructural disruption across disease stages in the Oxford Brain Health Clinic

Gillis G. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

Alzheimer's disease and its severity reduce MEG responses to unexpected auditory stimuli

Krugliak A. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

Evaluating the impact of the Oxford Brain Health Clinic pathway on psychiatrists' confidence in diagnosing memory disorders, and their perceived assessment usefulness

DU JIAMIN. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

The clinical and cost-effectiveness of sertraline in preventing depression in adults following a traumatic brain injury (STOP-D): study protocol for a multi-centre randomised controlled trial.

Burgess J. et al, (2025), Trials, 26

Alzheimer's disease and memantine effects on NMDA-receptor blockade: non-invasive in vivo insights from magnetoencephalography.

Lanskey JH. et al, (2025), Mol Psychiatry

Alzheimer's disease and its progression reduce pyramidal cell gain and connectivity.

Lanskey JH. et al, (2025), Alzheimers Dement, 21

Neurophysiological Progression in Alzheimer's Disease: Insights From Dynamic Causal Modelling of Longitudinal Magnetoencephalography.

Jafarian A. et al, (2025), Hum Brain Mapp, 46

Sports-related concussion not associated with long-term cognitive or behavioural deficits: the PROTECT-TBI study.

Lennon MJ. et al, (2025), J Neurol Neurosurg Psychiatry, 96, 397 - 405

Prevalence of dementia risk factors in the Oxford Brain Health Clinic.

Blane J. et al, (2025), Sci Rep, 15

From Big Data to the Clinic: Methodological and Statistical Enhancements to Implement the UK Biobank Imaging Framework in a Memory Clinic.

Gillis G. et al, (2025), Hum Brain Mapp, 46

Call up the (cognitive) reserves: how adult socialisation and education influences cognition in the UK Biobank.

Tari B. et al, (2025), Front Psychol, 16

Prevalence of dementia risk factors in a memory clinic setting: The Oxford Brain Health Clinic

Blane J. et al, (2024)

Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Journal of Neurotrauma.

Raymont V., (2024), J Neurotrauma, 41

From Big Data to the clinic: methodological and statistical enhancements to implement the UK Biobank imaging framework in a memory clinic

Gillis G. et al, (2024)

Neuroimaging and Clinical Findings in Healthy Middle-Aged Adults With Mild Traumatic Brain Injury in the PREVENT Dementia Study.

Low A. et al, (2024), JAMA Netw Open, 7

Reliability of dynamic causal modelling of resting-state magnetoencephalography.

Jafarian A. et al, (2024), Hum Brain Mapp, 45

The effect of Alzheimer’s disease and its progression on pyramidal cell gain and connectivity

Lanskey JH. et al, (2024)

Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial.

Creswell C. et al, (2024), Lancet Psychiatry, 11, 193 - 209

Specialist healthcare services for concussion/mild traumatic brain injury in England: a consensus statement using modified Delphi methodology.

Karvandi E. et al, (2023), BMJ Open, 13

Right BA 10 lesions impair performance on real-world planning but are not sensitive to problem novelty or tower tasks.

Goel V. et al, (2023), Cortex, 169, 353 - 373

Artificial intelligence for dementia prevention.

Newby D. et al, (2023), Alzheimers Dement, 19, 5952 - 5969

Reliability of dynamic causal modelling of resting state magnetoencephalography

Jafarian A. et al, (2023)

Oxford brain health clinic: protocol and research database.

O'Donoghue MC. et al, (2023), BMJ Open, 13

Understanding and managing the long-term cognitive consequences of traumatic brain injuries.

Woods M. et al, (2023), Br J Hosp Med (Lond), 84, 1 - 3

Lifetime Traumatic Brain Injury and Cognitive Domain Deficits in Late Life: The PROTECT-TBI Cohort Study.

Lennon MJ. et al, (2023), J Neurotrauma, 40, 1423 - 1435

Education is power: Preserving cognition in the UK Biobank

Tari B. et al, (2023)

A systematic review and meta-analysis of long COVID symptoms.

Natarajan A. et al, (2023), Syst Rev, 12

The indirect relationship between sleep and cognition in the PREVENT Cohort: Identifying targets for intervention

Tari B. et al, (2023)

An Evidence Based Methodological Framework for Pandemic Preparedness to Support the Clinical Trial Unit Workforce

Phiri P. et al, (2023)

The ELEMI healthcare professional Study

Delanerolle G. et al, (2023)

Impact of SARS-Cov-2 on Clinical Trial Unit Workforce in the United Kingdom: An Observational Study

Delanerolle G. et al, (2023)

The indirect relationship between sleep and cognition in the PREVENT cohort: identifying targets for intervention.

Tari B. et al, (2023), Front Sleep, 2

Education is power: preserving cognition in the UK biobank.

Tari B. et al, (2023), Front Public Health, 11

New Therapeutics in Alzheimer's Disease Longitudinal Cohort study (NTAD): study protocol.

Lanskey JH. et al, (2022), BMJ Open, 12

A randomised controlled trial to compare clinical and cost-effectiveness of an online parent-led treatment for child anxiety problems with usual care in the context of COVID-19 delivered in Child and Adolescent Mental Health Services in the UK (Co-CAT): a study protocol for a randomised controlled trial.

Taylor L. et al, (2022), Trials, 23

The impact of social isolation due to the COVID-19 pandemic on patients with dementia and caregivers.

Manca R. et al, (2022), Acta Neuropsychiatr, 34, 276 - 281

Mental health impact on Black, Asian and Minority Ethnic populations with preterm birth: A systematic review and meta-analysis.

Delanerolle G. et al, (2022), World J Psychiatry, 12, 1233 - 1254

Adapting UK Biobank imaging for use in a routine memory clinic setting: the Oxford Brain Health Clinic

Griffanti L. et al, (2022)

A randomised control trial to compare clinical and cost-effectiveness of an on-line parent-led treatment for child anxiety problems with usual care in the context of COVID-19 delivered in Child and Adolescent Mental Health Services (CAMHS) in the UK (Co-CAT): A study protocol for a randomised controlled trial

Taylor L. et al, (2022)

Impact of SARS-Cov-2 on Clinical Trial Unit Staff: The EPIC Observational Study

Phiri P. et al, (2022)

Impact of SARS-Cov-2 on Clinical Trial Unit workforce in the United Kingdom; An observational study

Delanerolle G. et al, (2022)

Alwyn Lishman's contribution to the neuropsychiatry of head injury (traumatic brain injury); two key papers.

Raymont V. and Fleminger S., (2022), Cogn Neuropsychiatry, 27, 289 - 295

The Oxford Brain Health Clinic: Protocol and Research Database

O’Donoghue MC. et al, (2022)

Mental health impact of the Middle East respiratory syndrome, SARS, and COVID-19: A comparative systematic review and meta-analysis.

Delanerolle G. et al, (2022), World J Psychiatry, 12, 739 - 765

Systematic Review and Meta-analysis of Mental Health Impact on BAME Populations with Preterm Birth

Delanerolle G. et al, (2022)

More publications